Abstract
The Expert Panel for Cosmetic Ingredient Safety reviewed newly available studies since their original assessment in year 2000, along with updated information regarding product types and concentrations of use, and confirmed that PEG-5, -10, -16, -25, -30, and -40 Soy Sterol are safe as cosmetic ingredients in the practices of use and concentration as described in this report.
Keywords
The Expert Panel for Cosmetic Ingredient Safety first published a Final Report on the Safety Assessment of PEG-5, -10, -16, -25, -30, and -40 Soy Sterol in 2000, with the conclusion that the data were insufficient to support the safety of this ingredient group. 1 Subsequently, additional data were received, and in 2004, the Expert Panel published an Amended Safety Assessment of PEG-5, -10, -16, -25, -30, and -40 Soy Sterol, with the conclusion that these six PEG Soy Sterol ingredients are safe as used in cosmetics, as described in the safety assessment. 2
Current and Historical Frequency and Concentration of Use according to Duration and Exposure.
aBecause each ingredient may be used in cosmetics with multiple exposure types, the sum of all exposure types may not equal the sum of total uses.
bIt is possible these products are sprays, but it is not specified whether the reported uses are sprays.
cIt is possible these products are powders, but it is not specified whether the reported uses are powders.
dNot specified whether a spray or a powder, but it is possible the use can be as a spray or a powder; therefore, the information is captured in both categories.
NR, no reported use.
An extensive search of the world’s literature was performed for studies dated 1998 forward. No new toxicity or safety data were found. After reviewing updated frequency and concentration of use data, and considering the lack of new toxicological or safety data, the Expert Panel determined to not reopen this safety assessment on the PEG Soy Sterol ingredients and reaffirmed the conclusion published in 2004.
Footnotes
Author’s Note
Unpublished sources cited in this report are available from the Director, Cosmetic Ingredient Review, 1620 L Street, NW, Suite 1200, Washington, DC 20036, USA.
Author Contributions
The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
Declaration of Conflicting Interest
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review. The Cosmetic Ingredient Review is financially supported by the Personal Care Products Council.